What is the management of phenobarbital (barbiturate) toxicity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Management of phenobarbital toxicity requires prompt supportive care and specific interventions, with the primary goal of reducing morbidity, mortality, and improving quality of life. Initial management includes airway protection, ventilatory support if needed, and hemodynamic stabilization with IV fluids and vasopressors for hypotension.

  • Activated charcoal (1 g/kg orally) should be administered if the patient presents within 1-2 hours of ingestion and has a protected airway, as it may help reduce absorption of the drug 1.
  • For severe toxicity, multiple-dose activated charcoal (15-20 g taken orally every 6 hours) may enhance elimination, but its use should be cautious due to the risk of impaction and gut perforation 1.
  • Urinary alkalinization is no longer recommended as first-line treatment in cases of barbiturate poisoning because it does not increase renal clearance significantly and MDAC is considered superior 1. In life-threatening cases, hemodialysis effectively removes phenobarbital and should be considered when levels exceed 100 mg/L or with severe clinical manifestations despite supportive care 1. Flumazenil is contraindicated as it doesn't reverse barbiturate effects and may precipitate seizures. Continuous monitoring of vital signs, neurological status, and serum phenobarbital levels is essential, with particular attention to respiratory depression, the most dangerous complication. Treatment should continue until clinical improvement occurs and phenobarbital levels fall below 40 mg/L. Phenobarbital has a long half-life (79-96 hours), so prolonged observation may be necessary even after apparent clinical improvement. The decision to perform ECTR should be based on clinical signs and symptoms of severe poisoning, rather than ingested dose and serum barbiturate concentrations alone 1.

From the FDA Drug Label

The toxic dose of barbiturates varies considerably. Barbiturate intoxication may be confused with alcoholism, bromide intoxication and various neurological disorders. For sedation, therapeutic blood levels of phenobarbital range from 5-40 µg/mL; the lethal blood level is greater than 80 µg/mL and usually ranges from 100-200 µg/mL Treatment of overdosage is mainly supportive and consists of the following: Maintenance of an adequate airway, with assisted respiration and oxygen administration as necessary. Monitoring of vital signs and fluid balance Fluid therapy and other standard treatment for shock, if needed. If renal function is normal, forced diuresis may aid in the elimination of the barbiturate. Alkalinization of the urine increases renal excretion of phenobarbital. Although not recommended as a routine procedure, hemodialysis may be used in severe barbiturate intoxication or if the patient is anuric or in shock Hemoperfusion through an anion-exchange resin or activated charcoal has been successful.

Management of Phenobarbital Toxicity

  • Maintain an adequate airway with assisted respiration and oxygen administration as necessary
  • Monitor vital signs and fluid balance
  • Provide fluid therapy and standard treatment for shock if needed
  • Consider forced diuresis if renal function is normal
  • Alkalinization of the urine may increase renal excretion of phenobarbital
  • Hemodialysis or hemoperfusion may be used in severe cases 2 Key considerations include:
  • Patient should be rolled from side to side every 30 minutes
  • Antibiotics should be given if pneumonia is suspected
  • Appropriate nursing care to prevent hypostatic pneumonia, decubiti, aspiration and other complications of patients with altered states of consciousness

From the Research

Management of Phenobarbital Toxicity

The management of phenobarbital toxicity involves several strategies to enhance the elimination of the drug from the body. Some of the key approaches include:

  • Urinary alkalinization: This method involves increasing the pH of the urine to increase the excretion of phenobarbital 3
  • Multiple-dose activated charcoal: This approach involves administering repeated doses of activated charcoal to absorb the drug and prevent its reabsorption into the bloodstream 3, 4, 5
  • Supportive care: This includes cardiac and respiratory support, as well as the use of cathartics and alkaline diuresis 6
  • Extracorporeal therapy: In severe cases, hemodialysis and hemoperfusion can be used to enhance drug clearance, and continuous renal replacement therapy may be considered if the patient's circulation is unstable 6, 7

Comparison of Treatment Modalities

Studies have compared the efficacy of different treatment modalities for phenobarbital toxicity. For example:

  • A study found that multiple-dose activated charcoal was superior to urinary alkalinization in enhancing phenobarbital elimination 3
  • Another study found that repeated doses of activated charcoal significantly increased the elimination of phenobarbital, but had no clear effects on the patients' clinical course 5
  • A case report described the successful treatment of a patient with severe phenobarbital poisoning using continuous renal replacement therapy 7

Clinical Considerations

The management of phenobarbital toxicity requires careful consideration of the patient's clinical condition and the severity of the overdose. For example:

  • Patients with severe phenobarbital poisoning may require mechanical ventilation and circulatory support 7
  • The use of extracorporeal therapy may be necessary in cases where the patient's circulation is unstable or the drug concentration is extremely high 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.